表紙
市場調查報告書

肺部藥物輸送的市場規模及預測(2019年∼2028年)

Global Pulmonary Drug Delivery Market Forecast 2019-2028

出版商 Inkwood Research 商品編碼 954845
出版日期 內容資訊 英文 248 Pages
商品交期: 2-3個工作天內
價格
肺部藥物輸送的市場規模及預測(2019年∼2028年) Global Pulmonary Drug Delivery Market Forecast 2019-2028
出版日期: 2020年08月22日內容資訊: 英文 248 Pages
簡介

全球肺部藥物輸送的市場規模,從2019年到2028年的預測年之間以5.06%的年複合成長率成長。藥物遞輸系統的技術在日常生活中發揮了重要作用,不斷進化著。因此導致生活方式的變化,便利性的需求,對採取更佳設備的必要性等創新產品的需求高漲,導致技術開發。肺部藥物輸送市場也同樣,受到技術進步的推動,預計產生潛在的成長機會。

本報告提供全球肺部藥物輸送的市場規模相關調查,成長及阻礙因素,COVID-19的影響,法規的框架,各用途、流通管道、終端用戶、產品、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查範圍與方法調查手法

  • 調查目的
  • 調查範圍
  • 調查手法
  • 前提條件與限制

第2章 摘要整理

  • 市場規模、估計
  • 市場概要

第3章 市場動態

  • 父母市場分析
  • 藥物遞輸系統的開發
  • 市場定義
  • 主要的成長要素
    • 呼吸疾病逐漸增加的盛行率
    • 技術的進步
    • 老年人口的增加
  • 主要的阻礙因素
    • 嚴格的法規和專利的有效期限
    • 藥物回收和藥物障礙的增加
    • 藥相關的副作用和風險

第4章 主要分析

  • 波特的五力分析
  • 法律規範
  • COVID-19對市場的影響
  • 市場機會矩陣
  • 業者情勢
  • 主要的投資洞察

第5章 市場分析:各用途

  • 氣喘
  • 慢性阻塞性肺病
  • 過敏性鼻炎
  • 囊狀纖維化症
  • 其他

第6章 市場分析:各流通管道

  • 院內藥局
  • 零售藥局
  • 電子商務

第7章 市場分析:各終端用戶

  • 醫院、診所
  • 居家護理

第8章 市場分析:各產品

  • 定量噴霧吸入器 (MDI)
  • 乾粉吸入劑 (DPI)
  • 噴霧器
    • 壓縮機式噴霧器
    • 篩孔式噴霧器
    • 超音波式噴霧器
  • 配件

第9章 市場分析:各地區

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 俄羅斯
    • 比利時
    • 波蘭
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲和紐西蘭
    • 韓國
    • 泰國
    • 印尼
    • 越南
    • 其他亞太地區
  • 其他地區
    • 南美
    • 中東、非洲

第10章 企業簡介

  • 3M COMPANY
  • ACTELION PHARMACEUTICALS LTD
  • AEROGEN
  • AGILENT TECHNOLOGIES INC
  • ASTRAZENECA PLC
  • BOEHRINGER INGELHEIM GMBH
  • CLEMENT CLARKE INTERNATIONAL
  • GF HEALTH PRODUCTS INC
  • GLAXOSMITHKLINE PLC
  • KONINKLIJKE PHILIPS NV
  • MERCK & CO INC
  • NOVARTIS AG
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED
  • VECTURA GROUP PLC
目錄
Product Code: 33327

KEY FINDINGS

The global pulmonary drug delivery market is anticipated to register a CAGR of 5.06%, during the forecast years of 2019 to 2028. The key drivers, such as advancements in technology, the surging prevalence of respiratory diseases, and the rising geriatric population, are attributed to market growth.

MARKET INSIGHTS

With its recent introduction into the pharmaceutical field, pulmonary drug delivery systems are used to treat both local as well as systemic types of lung diseases. They are characterized by their ability to directly deliver medication to the designated location in the body or other distant sites through the bloodstream. Moreover, different forms of drug delivery systems, including inhalers and nebulizers, were introduced as alternative treatments for diverse lung conditions.

Technology plays a crucial role in daily lives, and is consistently evolving. As a result, the rising demand for innovative products, incorporated with changing lifestyles, the need for convenience, and better facilities, leads to technological developments. Similarly, the market for pulmonary drug delivery is fuelled by rising advancements in technology, and is projected to generate potential growth opportunities. The limitations of conventional treatments, such as low efficacy and delayed onset of action, are also predicted to encourage the development of innovative and superior targeted drug delivery systems.

REGIONAL INSIGHTS

The global pulmonary drug delivery market growth is geographically analyzed through the Asia Pacific, Europe, North America, and the rest of the world. The Asia Pacific is projected to be the fastest-growing region, owing to the high incidence of chronic obstructive pulmonary disease (COPD), indicating significant socioeconomic problems. The rising number of patients with allergic rhinitis and asthma also contributes to the region's market growth.

COMPETITIVE INSIGHTS

The market is competitive, with major players engaged in constant product developments, in addition to partnership agreements to ease market penetration. Moreover, the growing number of dealers and distributors is predicted to intensify the industry rivalry, in the upcoming years. Leading companies operating in the market include, Boehringer Ingelheim GmbH, 3M Company, GlaxoSmithKline PLC, Koninklijke Philips NV, AstraZeneca PLC, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. PARENT MARKET ANALYSIS: DRUG DELIVERY MARKET
  • 3.2. DEVELOPMENT OF DRUG DELIVERY SYSTEM
  • 3.3. MARKET DEFINITION
  • 3.4. KEY DRIVERS
    • 3.4.1. GROWING PREVALENCE OF RESPIRATORY DISEASE
    • 3.4.2. ADVANCEMENTS IN TECHNOLOGY
    • 3.4.3. RISING GERIATRIC POPULATION
  • 3.5. KEY RESTRAINTS
    • 3.5.1. STRINGENT REGULATION AND PATENT EXPIRY
    • 3.5.2. INCREASING DRUG RECALLS AND DRUG FAILURES
    • 3.5.3. SIDE EFFECTS AND RISK ASSOCIATED WITH THE DRUGS

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. REGULATORY FRAMEWORK
  • 4.3. IMPACT OF COVID-19 ON PULMONARY DRUG DELIVERY MARKET
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE
  • 4.6. KEY INVESTMENT INSIGHTS

5. MARKET BY APPLICATION

  • 5.1. ASTHMA
  • 5.2. CHRONIC OBSTRUCTIVE PULMONARY DISEASE
  • 5.3. ALLERGIC RHINITIS
  • 5.4. CYSTIC FIBROSIS
  • 5.5. OTHER APPLICATIONS

6. MARKET BY DISTRIBUTION CHANNEL

  • 6.1. HOSPITAL PHARMACIES
  • 6.2. RETAIL PHARMACIES
  • 6.3. E-COMMERCE

7. MARKET BY END-USER

  • 7.1. HOSPITALS & CLINICS
  • 7.2. HOMECARE

8. MARKET BY PRODUCT

  • 8.1. METERED DOSE INHALERS
  • 8.2. DRY POWDER INHALERS
  • 8.3. NEBULIZER
    • 8.3.1. PNEUMATIC NEBULIZER
      • 8.3.1.1. BREATH ACTUATED PNEUMATIC NEBULIZER
      • 8.3.1.2. VENTED PNEUMATIC NEBULIZER
    • 8.3.2. MESH NEBULIZER
      • 8.3.2.1. VIBRATING MESH NEBULIZER
      • 8.3.2.2. STATIC MESH NEBULIZER
    • 8.3.3. ULTRASONIC NEBULIZER
  • 8.4. ACCESSORIES

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. THE UNITED STATES
    • 9.1.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. GERMANY
    • 9.2.2. THE UNITED KINGDOM
    • 9.2.3. FRANCE
    • 9.2.4. ITALY
    • 9.2.5. RUSSIA
    • 9.2.6. BELGIUM
    • 9.2.7. POLAND
    • 9.2.8. REST OF EUROPE
  • 9.3. ASIA PACIFIC
    • 9.3.1. CHINA
    • 9.3.2. JAPAN
    • 9.3.3. INDIA
    • 9.3.4. AUSTRALIA & NEW ZEALAND
    • 9.3.5. SOUTH KOREA
    • 9.3.6. THAILAND
    • 9.3.7. INDONESIA
    • 9.3.8. VIETNAM
    • 9.3.9. REST OF ASIA PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. LATIN AMERICA
    • 9.4.2. MIDDLE EAST & AFRICA

10. COMPANY PROFILES

  • 10.1. 3M COMPANY
  • 10.2. ACTELION PHARMACEUTICALS LTD
  • 10.3. AEROGEN
  • 10.4. AGILENT TECHNOLOGIES INC
  • 10.5. ASTRAZENECA PLC
  • 10.6. BOEHRINGER INGELHEIM GMBH
  • 10.7. CLEMENT CLARKE INTERNATIONAL
  • 10.8. GF HEALTH PRODUCTS INC
  • 10.9. GLAXOSMITHKLINE PLC
  • 10.10. KONINKLIJKE PHILIPS NV
  • 10.11. MERCK & CO INC
  • 10.12. NOVARTIS AG
  • 10.13. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
  • 10.14. VECTURA GROUP PLC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - PULMONARY DRUG DELIVERY
  • TABLE 2: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL ASTHMA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: GLOBAL ASTHMA MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL ALLERGIC RHINITIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: GLOBAL ALLERGIC RHINITIS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL CYSTIC FIBROSIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 11: GLOBAL CYSTIC FIBROSIS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 13: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 15: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 17: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL RETAIL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 19: GLOBAL RETAIL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL E-COMMERCE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 21: GLOBAL E-COMMERCE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 23: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 25: GLOBAL HOSPITALS & CLINICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL HOMECARE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 27: GLOBAL HOMECARE MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 29: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL METERED DOSE INHALERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 31: GLOBAL METERED DOSE INHALERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL DRY POWDER INHALERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 33: GLOBAL DRY POWDER INHALERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL NEBULIZER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 35: GLOBAL NEBULIZER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL NEBULIZER MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 37: GLOBAL NEBULIZER MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL PNEUMATIC NEBULIZER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 39: GLOBAL PNEUMATIC NEBULIZER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 40: GLOBAL PNEUMATIC NEBULIZER MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 41: GLOBAL PNEUMATIC NEBULIZER MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 42: GLOBAL MESH NEBULIZER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 43: GLOBAL MESH NEBULIZER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 44: GLOBAL MESH NEBULIZER MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 45: GLOBAL MESH NEBULIZER MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 46: GLOBAL ULTRASONIC NEBULIZER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 47: GLOBAL ULTRASONIC NEBULIZER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 48: GLOBAL ACCESSORIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 49: GLOBAL ACCESSORIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 50: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 51: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY REGION MARKET, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 52: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 53: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 54: EUROPE PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 55: EUROPE PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 56: ASIA PACIFIC PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 57: ASIA PACIFIC PULMONARY DRUG DELIVERY MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 58: REST OF WORLD PULMONARY DRUG DELIVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 59: REST OF WORLD PULMONARY DRUG DELIVERY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL POPULATION, BY AGE GROUP 2015 & 2020 (IN MILLION)
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: KEY INVESTMENT INSIGHTS
  • FIGURE 6: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY APPLICATION, IN 2019
  • FIGURE 7: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY ASTHMA, 2019-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY ALLERGIC RHINITIS, 2019-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY CYSTIC FIBROSIS, 2019-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, IN 2019
  • FIGURE 13: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY HOSPITAL PHARMACIES, 2019-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY RETAIL PHARMACIES, 2019-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY E-COMMERCE, 2019-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY END-USER, IN 2019
  • FIGURE 17: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY HOSPITALS & CLINICS, 2019-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY HOMECARE, 2019-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY PRODUCT, IN 2019
  • FIGURE 20: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY METERED DOSE INHALERS, 2019-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY DRY POWDER INHALERS, 2019-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY NEBULIZER, 2019-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL NEBULIZER MARKET, BY PNEUMATIC NEBULIZER, 2019-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL PNEUMATIC NEBULIZER MARKET, BY BREATH ACTUATED PNEUMATIC NEBULIZER, 2019-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL PNEUMATIC NEBULIZER MARKET, BY VENTED PNEUMATIC NEBULIZER, 2019-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL NEBULIZER MARKET, BY MESH NEBULIZER, 2019-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL MESH NEBULIZER MARKET, BY VIBRATING MESH NEBULIZER, 2019-2028 (IN $ MILLION)
  • FIGURE 28: GLOBAL MESH NEBULIZER MARKET, BY STATIC MESH NEBULIZER, 2019-2028 (IN $ MILLION)
  • FIGURE 29: GLOBAL NEBULIZER MARKET, BY ULTRASONIC NEBULIZER, 2019-2028 (IN $ MILLION)
  • FIGURE 30: GLOBAL PULMONARY DRUG DELIVERY MARKET, BY ACCESSORIES, 2019-2028 (IN $ MILLION)
  • FIGURE 31: NORTH AMERICA PULMONARY DRUG DELIVERY MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 32: THE UNITED STATES PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 33: CANADA PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 34: EUROPE PULMONARY DRUG DELIVERY MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 35: GERMANY PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 36: THE UNITED KINGDOM PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 37: FRANCE PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 38: ITALY PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 39: RUSSIA PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 40: BELGIUM PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 41: POLAND PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 42: REST OF EUROPE PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 43: ASIA PACIFIC PULMONARY DRUG DELIVERY MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 44: CHINA PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 45: JAPAN PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 46: INDIA PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 47: AUSTRALIA & NEW ZEALAND PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 48: SOUTH KOREA PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 49: THAILAND PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 50: INDONESIA PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 51: VIETNAM PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 52: REST OF ASIA PACIFIC PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 53: REST OF WORLD PULMONARY DRUG DELIVERY MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 54: LATIN AMERICA PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 55: MIDDLE EAST & AFRICA PULMONARY DRUG DELIVERY MARKET, 2019-2028 (IN $ MILLION)